Seven Years Later: TAVR Didn't Blink 😎🫀
Dr RR Baliga's "Got Knowledge Doc" Podkast
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🫀 TAVR or SAVR? The 7-Year Truth
New 7-year results from the PARTNER-3 trial (NEJM) show that in low-risk patients with severe symptomatic aortic stenosis, TAVR holds pace with surgery — delivering comparable survival, stroke rates, rehospitalization, valve durability, and quality-of-life outcomes.
🔎 Highlights
• Composite events: 34.6% (TAVR) vs 37.2% (SAVR)
• Mortality: 19.5% vs 16.8%
• Valve failure: 6.9% vs 7.3%
• Aortic gradients remain low in both groups
💡 Clinical rhythm: less AF with TAVR; more pacemakers and paravalvular leak.
This study reinforces a simple truth: in the right low-risk patient, TAVR is not just less invasive — it's durable.
#Cardiology #StructuralHeart #AorticStenosis #TAVR #SAVR #NEJM